Literature DB >> 11751982

Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.

Martin Mempel1, Catherine Ronet, Felipe Suarez, Martine Gilleron, Germain Puzo, Luc Van Kaer, Agnès Lehuen, Philippe Kourilsky, Gabriel Gachelin.   

Abstract

Murine Valpha14(inv)T cells (NKT cells), restricted by the CD1d1 MHC 1b molecules, are a distinctive subset of T cells endowed with pleiotropic functions. CD1d1-restricted NKT cells infiltrate the granulomas induced by the s.c. injection of mycobacterial phosphatidylinositoldimannoside (PIM(2)) but not of its deacylated derivative. NKT cells are detectable as early as 6 hours following the injection. Although the molecular structure of PIM(2) meets the requirements for presentation by CD1d1, Ab blocking and adoptive transfer experiments of wild-type NKT cells into CD1d1(-/-) mice show that CD1d1 expression is not required for the early recruitment of NKT cells to the injection site. This conclusion was confirmed by the finding that IL-12Rbeta(-/-) and CD40(-/-) mice were able to recruit NKT cells after PIM(2) challenge. Moreover, the injection of alpha-galactosylceramide, an NKT cell ligand that is recognized in the context of CD1d1, promoted only a minor recruitment of NKT cells. By contrast, injection of beta-galactosylceramide, a synthetic glycolipid that binds to CD1d1 but does not activate the CD1d/TCR pathway, resulted in the development of large granulomas rich in NKT cells. Finally, local injection of TNF-alpha mimics the effect of glycolipids. It is concluded that NKT cells migrate to and accumulate at inflammatory sites in the same way as other cells of the innate immune system and that migration to and accumulation at inflammatory sites are processes independent of the CD1d1 molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751982     DOI: 10.4049/jimmunol.168.1.365

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.

Authors:  Gary D Ainge; William John Martin; Benjamin J Compton; Colin M Hayman; David S Larsen; Sung-Il Yoon; Ian A Wilson; Jacquie L Harper; Gavin F Painter
Journal:  J Med Chem       Date:  2011-10-05       Impact factor: 7.446

Review 2.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 3.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  CD1d-restricted NKT cells modulate placental and uterine leukocyte populations during chlamydial infection in mice.

Authors:  Mohamed Habbeddine; Philippe Verbeke; Christiane Delarbre; René Moutier; Stéphane Prieto; David M Ojcius; Colette Kanellopoulos-Langevin
Journal:  Microbes Infect       Date:  2013-08-31       Impact factor: 2.700

Review 5.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

6.  T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells.

Authors:  Jennifer L Matsuda; Qianjun Zhang; Rachel Ndonye; Stewart K Richardson; Amy R Howell; Laurent Gapin
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

7.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

8.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

9.  The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis.

Authors:  H G Yu; D S Lee; J M Seo; J K Ahn; Y S Yu; W J Lee; H Chung
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.

Authors:  Chris M Olson; Tonya C Bates; Hooman Izadi; Justin D Radolf; Sally A Huber; Jonathan E Boyson; Juan Anguita
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.